| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
United Therapeutics Corp last filed a Form 4 in December 2019, as 10% Owner at TMDX.
At the last filing, the largest reported position was 2,053,240 shares of TMDX. The TMDX filings lean toward selling, a net 500,000 shares.
United Therapeutics Corp has 2 Form 4 filings on record from May 2019 to December 2019, all as 10% Owner at TransMedics Group (TMDX), 2019.
The 2 reported transactions were 1 open-market sale and 1 conversion.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $9.4M.
The only open-market sale was 500,000 shares of TMDX at an average $18.75 on December 9, 2019, about $9.4M.
Shares as reported in the last Form 4 for each company; the most recent is from December 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2019 | TMDX Transmedics Group, Inc. | 10% Owner | Sell | 500,000 | $18.75 | $9,375,000.00 | -19.6% |